Triall cena 

TRL

Triall was founded by a group of clinical operations experts, enterprise IT specialists, and blockchain developers.

Combined, their team has managed 100+ clinical trials, co-founded 20+ business ventures, and published 250+ peer-reviewed papers on innovation in medical research. This experience has left Triall with an extensive network within clinical research and the Life Sciences at large.

Triall has built an international network of partners and a global advisory board consisting of industry experts and Key Opinion Leaders that support the project in the buildout of its blockchain-enabled ecosystem.

As frontrunner in the clinical trials industry, Triall applies blockchain technology to address two industry-wide needs: (1) promoting traceability and auditability of clinical trial operations, which have become increasingly complex and data-heavy; and (2) enabling secure and compliant transfer of clinical trial data between organizations and systems, thereby promoting interoperability and tackling the growing problem of data fragmentation.

Triall takes an ‘ecosystem approach’ that is unique to the clinical trials industry: by enabling secure and compliant integrations between currently isolated clinical trial software, the project aims to turn current competitors into cooperators for the benefit of faster and more-efficient clinical trials. To this end, the project leverages emerging open blockchain standards such as Decentralized Identifiers (DIDs) and Verifiable Credentials (VCs). These will shape a decentralized identity and access management infrastructure for connecting systems and their users in a secure environment.